• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏瓣膜手术后复发性感染性心内膜炎与初发性感染性心内膜炎的比较。

Recurrent infective endocarditis versus first-time infective endocarditis after heart valve surgery.

机构信息

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen Ø, Denmark.

Department of Cardiothoracic Surgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

出版信息

Clin Res Cardiol. 2020 Nov;109(11):1342-1351. doi: 10.1007/s00392-020-01628-7. Epub 2020 Mar 17.

DOI:10.1007/s00392-020-01628-7
PMID:32185504
Abstract

OBJECTIVE

Infective endocarditis (IE) may require heart valve surgery. It is well known that heart valve surgery itself and previous IE predispose to IE. However, data are sparse on whether the risk of IE is different among patients undergoing valve surgery due to IE and other causes (i.e. recurrent vs. first-time IE).

METHODS

Using Danish nationwide registries, patients undergoing left-sided heart valve surgery in the course of an IE hospitalization (1996-2017) were identified and matched with controls undergoing left-sided heart valve surgery due to another cause than IE in a 1:1 ratio. Patients were stratified according to type of surgical valve intervention and affected valve. The comparative risk of recurrent vs. first-time IE was assessed by cumulative incidence curves and multivariable Cox regression analyses.

RESULTS

The study population comprised 971 patients with a first-time admission for IE requiring heart valve surgery matched with 971 controls undergoing heart valve surgery due to other causes than IE. The risk of recurrent IE was significantly higher than the risk of first-time IE following heart valve surgery (5.5% and 3.0% by 10 years, hazard ratio (HR) 1.66, 95% confidence interval (CI) 1.02-2.70). The risk of IE recurrence was not significantly different comparing valve replacement and valve repair (5.5% and 5.3%, respectively, HR 1.60, 95% CI 0.71-3.60). Yet, the risk of IE recurrence was significantly higher among patients with biological versus mechanical prostheses (6.3% and 4.6%, respectively, HR 2.00, 95% CI 1.02-3.70).

CONCLUSIONS

Following heart valve surgery, the risk of recurrent IE was significantly higher than the risk of first-time IE.

摘要

目的

感染性心内膜炎(IE)可能需要心脏瓣膜手术。众所周知,心脏瓣膜手术本身以及先前的 IE 会增加 IE 的发病风险。然而,关于因 IE 和其他原因(即复发性与首次 IE)而接受瓣膜手术的患者,IE 的风险是否不同,相关数据却很少。

方法

利用丹麦全国性登记处,确定在 IE 住院期间接受左侧心脏瓣膜手术的患者,并按 1:1 的比例与因 IE 以外的其他原因接受左侧心脏瓣膜手术的对照组相匹配。根据手术瓣膜干预类型和受影响的瓣膜对患者进行分层。通过累积发病率曲线和多变量 Cox 回归分析评估复发性 IE 与首次 IE 的相对风险。

结果

该研究人群包括 971 例首次因 IE 需行心脏瓣膜手术的患者,与 971 例因 IE 以外的其他原因而行心脏瓣膜手术的对照组相匹配。与心脏瓣膜手术后首次 IE 相比,心脏瓣膜手术后复发性 IE 的风险显著更高(10 年时分别为 5.5%和 3.0%,风险比 (HR) 1.66,95%置信区间 (CI) 1.02-2.70)。瓣膜置换术和瓣膜修复术的 IE 复发风险无显著差异(分别为 5.5%和 5.3%,HR 1.60,95% CI 0.71-3.60)。然而,生物假体与机械假体的 IE 复发风险存在显著差异(分别为 6.3%和 4.6%,HR 2.00,95% CI 1.02-3.70)。

结论

心脏瓣膜手术后,复发性 IE 的风险显著高于首次 IE 的风险。

相似文献

1
Recurrent infective endocarditis versus first-time infective endocarditis after heart valve surgery.心脏瓣膜手术后复发性感染性心内膜炎与初发性感染性心内膜炎的比较。
Clin Res Cardiol. 2020 Nov;109(11):1342-1351. doi: 10.1007/s00392-020-01628-7. Epub 2020 Mar 17.
2
Incidence of infective endocarditis in patients considered at moderate risk.感染性心内膜炎在中等风险患者中的发生率。
Eur Heart J. 2019 May 1;40(17):1355-1361. doi: 10.1093/eurheartj/ehy629.
3
Incidence and factors associated with infective endocarditis in patients undergoing left-sided heart valve replacement.行左侧心脏瓣膜置换术患者感染性心内膜炎的发生率及相关因素。
Eur Heart J. 2018 Jul 21;39(28):2668-2675. doi: 10.1093/eurheartj/ehy153.
4
Incidence of infective endocarditis among patients considered at high risk.高危患者感染性心内膜炎的发生率。
Eur Heart J. 2018 Feb 14;39(7):623-629. doi: 10.1093/eurheartj/ehx682.
5
Outcomes of surgery for infective endocarditis in children: A 30-year experience.儿童感染性心内膜炎手术治疗的结果:30 年经验。
J Thorac Cardiovasc Surg. 2019 Nov;158(5):1399-1409. doi: 10.1016/j.jtcvs.2019.06.024. Epub 2019 Jun 20.
6
Long-Term Risk of Infective Endocarditis After Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后感染性心内膜炎的长期风险。
J Am Coll Cardiol. 2019 Apr 9;73(13):1646-1655. doi: 10.1016/j.jacc.2018.12.078.
7
Cardiac implantable electronic device and associated risk of infective endocarditis in patients undergoing aortic valve replacement.心脏植入式电子设备与主动脉瓣置换术患者感染性心内膜炎的相关风险。
Europace. 2018 Oct 1;20(10):e164-e170. doi: 10.1093/europace/eux360.
8
Mechanical versus biological valve prosthesis for surgical aortic valve replacement in patients with infective endocarditis.感染性心内膜炎患者行外科主动脉瓣置换时机械瓣膜与生物瓣膜假体的比较
Interact Cardiovasc Thorac Surg. 2019 Sep 1;29(3):386-392. doi: 10.1093/icvts/ivz122.
9
Nationwide Registry-Based Analysis of Infective Endocarditis Risk After Pulmonary Valve Replacement.全国基于注册的肺瓣置换术后感染性心内膜炎风险分析。
J Am Heart Assoc. 2022 Mar;11(5):e022231. doi: 10.1161/JAHA.121.022231. Epub 2022 Feb 18.
10
Homograft Versus Conventional Prosthesis for Surgical Management of Aortic Valve Infective Endocarditis: A Systematic Review and Meta-analysis.同种异体移植物与传统人工瓣膜用于主动脉瓣感染性心内膜炎手术治疗的系统评价和荟萃分析。
Innovations (Phila). 2018 May/Jun;13(3):163-170. doi: 10.1097/IMI.0000000000000510.

引用本文的文献

1
Recurrences of the infective endocarditis: clinical features and outcomes. Results from the Polish infective endocarditis registry (POL-ENDO).感染性心内膜炎的复发:临床特征与结局。波兰感染性心内膜炎登记处(POL-ENDO)的结果。
Int J Cardiol Heart Vasc. 2025 Jul 28;60:101743. doi: 10.1016/j.ijcha.2025.101743. eCollection 2025 Oct.
2
Surgery in patients with infective endocarditis and prognostic importance of patient frailty.感染性心内膜炎患者的手术治疗和患者脆弱性的预后意义。
Infection. 2024 Oct;52(5):1953-1963. doi: 10.1007/s15010-024-02262-5. Epub 2024 Apr 27.
3
Survival and Recurrence of Endocarditis following Mechanical vs. Biological Aortic Valve Replacement for Endocarditis in Patients Aged 40 to 65 Years: Data from the INFECT-Registry.
40至65岁感染性心内膜炎患者行机械瓣与生物瓣主动脉瓣置换术后心内膜炎的生存及复发情况:来自INFECT注册研究的数据
J Clin Med. 2023 Dec 27;13(1):153. doi: 10.3390/jcm13010153.
4
Self-assessed health status and associated mortality in endocarditis: secondary findings from the POET trial.自身健康评估状况与心内膜炎相关死亡率:POET 试验的次要发现。
Qual Life Res. 2022 Sep;31(9):2655-2662. doi: 10.1007/s11136-022-03126-x. Epub 2022 Mar 29.
5
Incidence of infective endocarditis during the coronavirus disease 2019 pandemic: A nationwide study.2019年冠状病毒病大流行期间感染性心内膜炎的发病率:一项全国性研究。
Int J Cardiol Heart Vasc. 2020 Nov 6;31:100675. doi: 10.1016/j.ijcha.2020.100675. eCollection 2020 Dec.
6
The diagnostic benefit of 16S rDNA PCR examination of infective endocarditis heart valves: a cohort study of 146 surgical cases confirmed by histopathology.16S rDNA PCR 检查对感染性心内膜炎心瓣膜的诊断益处:经组织病理学证实的 146 例手术病例的队列研究。
Clin Res Cardiol. 2021 Mar;110(3):332-342. doi: 10.1007/s00392-020-01678-x. Epub 2020 Jun 2.